CONGRESS GUIDE

Recommendations

Info

ERS International Congress 2016 DETAILED PROGRAMME WEDNESDAY 07 SEPTEMBER, 2016 OA4954 OA4955 OA4956 Non-invasive urinary lipid mediator excretion profiles identify sub-phenotypes of asthma in the U-BIOPRED study Johan Kolmert (Stockholm, Sweden), Johan Kolmert, Cristina Gomez, Diane Lefaudeux, Bertrand DeMeulder, Anna James, Charles Auffray, Craig Wheelock, Sven-Erik Dahlen Asthma patients hospitalized with influenza lack mucosal and systemic type 2 inflammation Akhilesh Jha (London, United Kingdom), Akhilesh Jha, Jake Dunning, Tanushree Tunstall, Trevor Hansel, Peter Openshaw Serum level directed itraconazole therapy in allergic bronchopulmonary aspergillosis Kshitij Agarwal (New Delhi, India), Kshitij Agarwal, Roger Bruggemann, Anuradha Chowdhary, J.F. Meis, S.N. Gaur OA4957 Dipeptidyl peptidase I (DPPI) cleaves surfactant protein D (SP-D): A mechanism for immune compromise in the lung Yaroslav Shkanov (London, United Kingdom), Yaroslav Shkanov, Rose-Marie A. Mackay, Rhys George, Laurie C.K. Lau, Rana Abadalkareem, John Pedersen, Andrew F. Walls Room C Session 710 10:45 - 12:45 Oral Presentation: IPF treatment II Chairs : Luca Richeldi (Southampton, United Kingdom), Ulrich Costabel (ESSEN, Germany) OA4958 LATE-BREAKING ABSTRACT: Significant improvement in refractory chronic cough with inhaled PA101 in patients with idiopathic pulmonary fibrosis: Results from phase 2 trial Ahmet Tutuncu (San Diego, United States of America), Surinder Birring, Marlies Wijsenbeek, Sanjay Agrawal, Ahmet Tutuncu, Alyn Morice OA4959 OA4960 OA4961 OA4962 OA4963 OA4964 No effect of baseline diffusing capacity of lung for carbon monoxide on benefit of nintedanib Toby Maher (St. Albans, Hertfordshire, United Kingdom), Toby Maher, Kevin R. Flaherty, Yoshikazu Inoue, Luca Richeldi, Moisés Selman, Wibke Stansen, Susanne Stowasser, Athol Wells Long-term treatment with nintedanib in patients with IPF: An update from INPULSIS®-ON Bruno Crestani (Paris, France), Bruno Crestani, Manuel Quaresma, Mitchell Kaye, Wibke Stansen, Susanne Stowasser, Michael Kreuter Clinical experience with nintedanib for IPF in 3 UK tertiary referral centres Hannah Toellner (Burntisland, United Kingdom), Hannah Toellner, W. Beswick, M.G. Crooks, C. Donaldson, I. Forrest, S.P. Hart, C. Leonard, M. Major, A.J. Simpson, N. Chaudhuri Effect of baseline statin use on benefit of nintedanib Michael Kreuter (Heidelberg, Germany), Michael Kreuter, Ulrich Costabel, Luca Richeldi, Vincent Cottin, Daniel Wachtlin, Susanne Stowasser, Martin Kolb Relationship between nintedanib exposure and adverse events in patients with idiopathic pulmonary fibrosis Ulrike Schmid (Biberach an der Riss, Germany), Ulrike Schmid, Benjamin Weber, Claudia Dallinger, Luca Richeldi, Christoph Hallmann, Ganesh Raghu, Matthias Freiwald Predicting life expectancy for pirfenidone and best supportive care (BSC) in idiopathic pulmonary fibrosis (IPF) Mark Fisher (St Albans, United Kingdom), Mark Fisher, Toby M. Maher, Steven D. Nathan, Christian Hill, Jade Marshall, Fred Dejonckheere, Per-Olof Thuresson, Nitya Mathew OA4965 Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF) Elisabetta Balestro (Padova, Italy), Elisabetta Balestro, Graziella Turato, Davide Biondini, Sofia Pavanello, Alessia Fraccaro, Chiara Rigobello, Erica Bazzan, Manuela Campisi, Simonetta Baraldo, Manuel Cosio, Marina Saetta, Paolo Spagnolo Room G Session 711 10:45 - 12:45 Oral Presentation: Monitoring airway diseases with different tools Chairs : Renaud Louis (LIEGE, Belgium), Paul Brinkman (Amsterdam, Netherlands) OA6005 Introduction talk: Guiding treatment strategies in asthma: Which is best recipe? Renaud Louis (LIEGE, Belgium) OA4967 OA4968 The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients Marija Kojicic Vukoja (Sremska Kamenica, Republic of Serbia), Marija Kojicic Vukoja, Dragana Milicic, Miroslav Ilic, Ivan Kopitovic Validation of impulse oscillometry R5-R20 as a small airways dysfunction detection tool in adult asthma Marcia Soares (Leicester, United Kingdom), Marcia Soares, Rafel Bordas, James Thorpe, Breanda Timmerman, Christopher Brightling, David Kay, Kelly Burrowes, Owers-Bradley John, Salman Siddiqui 322 26.08.2016
ERS International Congress 2016 DETAILED PROGRAMME WEDNESDAY 07 SEPTEMBER, 2016 OA4969 OA4970 OA4971 OA4972 Influence of written action plans and patient education on future hospital admissions – Results from the disease management program (DMP) asthma in the North Rhine region in Germany Arne Weber (Köln, Germany), Arne Weber, Bernd Hagen, Sabine Groos, Jens Kretschmann Calculation of peripheral airspace dimensions from deposition of inhaled nanoparticles Jakob Löndahl (Lund, Sweden), Jakob Löndahl, Jonas Jakobsson, David M. Broday, Laura H. Aaltonen, Per Wollmer Optical coherence tomography for human airway wall layer identification and quantification Julia d'Hooghe (Amsterdam, Netherlands), Julia N.S. d’Hooghe, Daniel M. de Bruin, Joris J.T.H. Roelofs, Jouke T. Annema, Peter I. Bonta Limitations of nasal nitric oxide as a screening method of primary ciliary dyskinesia in childhood Maria Teresa Romero Rubio (Valencia, Spain), Maria Teresa Romero Rubio, Prieto Andrés Jesús Luis, Armengot Carceller Miguel, Escribano Montaner Amparo OA4973 Self-efficacy in patients with COPD using an online selfmanagement program Geertje de Boer (Rotterdam, Netherlands), Geertje de Boer, Bianka Mennema, Esther van Noort, Erwin Birnie, Johannes In ’t Veen Room D Session 712 10:45 - 12:45 Oral Presentation: Emerging concepts in lung disease pathogenesis Chairs : Mark Gjomarkaj (Palermo, Italy), Pieter S. Hiemstra (Leiden, Netherlands) OA4974 LATE-BREAKING ABSTRACT: Airway recruitment and anti-viral function of dendritic cells in asthmatic patients during RV-16 infection Aoife Cameron (London, United Kingdom), Aoife Cameron, Jaideep Dhariwal, Sebastian Johnston, Ross Walton OA4975 OA4976 OA4977 OA4978 OA4979 OA4980 The novel myokine irisin interacts with hyaluronic acid in a cell-specific way and in association with COPD progression and severity Eleni Papakonstantinou (Thessaloniki, Greece), Eleni Papakonstantinou, Michael Roth, Jyotshna Mandal, Michael Tamm, Daiana Stolz Rhinovirus-induced IL-33 expression in asthmatic airway smooth muscle cells is TLR3-dependent and involves activation of TAK1 Jenny Calvén (Lund, Sweden), Jenny Calvén, Hamid Akbarshahi, Sangeetha Ramu, Charalambos Michaeloudes, Kian Fan Chung, Lena Uller The key role of microRNA-34a in the reduction of sirtuin-1 in COPD Jonathan R. Baker (London, United Kingdom), Jonathan Baker, Tom Colley, Kaz Ito, Peter Barnes Involvement of ferroptosis in COPD pathogenesis Masahiro Yoshida (Tokyo, Japan), Masahiro Yoshida, Shunsuke Minagawa, Jun Araya, Hiromichi Hara, Nayuta Saito, Nahoko Sato, Kazuya Tsubouchi, Yusuke Kurita, Kenji Kobayashi, Saburo Ito, Takanori Numata, Yumi Kaneko, Katsutoshi Nakayama, Kazuyoshi Kuwano SH2 domain-containing phosphatase-SHP-2 is a novel anti-fibrotic regulator in pulmonary fibrosis Argyris Tzouvelekis (ATHENS, Greece), Argyris Tzouvelekis, Guoying Yu, Jose Herazo-Maya, Tony Woolard, Yi Zhang, Hojin Lee, Patty Lee, Erica Herzog, Anton Bennett, Naftali Kaminski Axl receptor tyrosine kinase drives cell cycle re-entry and promotes symmetric cell division of airway basal cells in response to injury Naoya Fujino (Molndal, Sweden), Naoya Fujino, Toshifumi Fujimori, Rose Maciewicz, Tracy Hussell OA4981 Hidden dangers of E-cigarettes: Airway macrophage dysfunction and altered inflammatory response Miranda Ween (Adelaide, Australia), Miranda Ween, Paul Reynolds, Sandra Hodge Room M Session 713 10:45 - 12:45 Oral Presentation: Paediatric respiratory infection and immunology Chairs : Mark Everard (Perth, Australia), Ricardo Fernandes (Lisbon, Portugal) OA4982 LATE-BREAKING ABSTRACT: The impact of a persistent bacterial bronchitis on the pulmonary microbiome of children Vanessa Craven (Sheffield, United Kingdom), Leah Cuthbertson, Heather Elphick, Lynne Bingle, William Cookson, Mark Everard 323 26.08.2016
Page 1:
HELP SHAPE THE FUTURE OF RESPIRATOR
Page 4 and 5:
WELCOME FROM THE CONGRESS CHAIRS ER
Page 6 and 7:
ERS LONDON 2016 Data scanning syste
Page 8 and 9:
MAPS ERS LONDON 2016 ■ CONGRESS M
Page 10 and 11:
MAPS ERS LONDON 2016 ■ EXHIBITION
Page 12 and 13:
ERS MAPSWORLD VILLAGE ERS LONDON 20
Page 14 and 15:
INVITATION JOIN US AT THE OPENING C
Page 16 and 17:
CONGRESS RESOURCES AREA Te Congress
Page 18 and 19:
ERS-SPLF Joint Session Saturday 3 S
Page 20 and 21:
ERS-CTS Joint Session Saturday 3 Se
Page 22 and 23:
PROGRAMME AT A GLANCE
Page 24 and 25:
ERS International Congress 2016 OUT
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
WORLD VILLAGE SESSIONS
Page 44 and 45:
PROGRAMME DETAILS
Page 46 and 47:
ERS International Congress 2016 DET
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
ERS International Congress 2016 Roo
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
ERS International Congress 2016 T-0
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
ERS International Congress 2016 Pla
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
ERS International Congress 2016 ICC
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
Page 272 and 273:
Page 274 and 275:
Page 276 and 277:
Page 278 and 279:
Page 280 and 281:
Page 282 and 283:
Page 284 and 285:
Page 286 and 287:
Page 288 and 289:
Page 290 and 291:
Page 292 and 293:
Page 294 and 295:
Page 296 and 297:
Page 298 and 299:
Page 300 and 301:
Page 302 and 303:
Page 304 and 305:
Page 306 and 307:
Page 308 and 309:
Page 310 and 311:
Page 312 and 313:
Page 314 and 315:
Page 316 and 317: ERS International Congress 2016 DET
Page 338 and 339: ERS International Congress 2016 13:
Page 354 and 355: ERS International Congress 2016 Pla
Page 378 and 379: ERS International Congress 2016 WOR
Page 384 and 385: ERS International Congress 2016 IND
Page 388 and 389: INDUSTRY SPONSORED SESSIONS DISCLAI
Page 408 and 409: CHAIR AND COORDINATOR INDEX Name, S
Page 410 and 411: CHAIR AND COORDINATOR INDEX S., 456
Page 412 and 413: SPEAKER INDEX 4753, 4758, 4759 GIBS
Page 414 and 415: SPEAKER INDEX ZAR H., 1734 ZAVORSKY
Page 416 and 417:
AUTHOR INDEX AKHTER S., PA1020, 118
Page 418 and 419:
AUTHOR INDEX ARAUJO SILVA C., PA136
Page 420 and 421:
AUTHOR INDEX 4323, 4866, 4869 BARBA
Page 422 and 423:
AUTHOR INDEX BILTON D., PA2633, PA4
Page 424 and 425:
AUTHOR INDEX BROWN M., PA5047 BROWN
Page 426 and 427:
AUTHOR INDEX PA2759 CASTIGLIA D., P
Page 428 and 429:
AUTHOR INDEX ALVAREZ B., PA1034 CIM
Page 430 and 431:
AUTHOR INDEX D’ORAZIO C., OA1489,
Page 432 and 433:
AUTHOR INDEX DEVRAJ M., PA2689 DEWA
Page 434 and 435:
AUTHOR INDEX EL ANDALOUSSI M., PA25
Page 436 and 437:
AUTHOR INDEX PA2634, PA2636, 3266,
Page 438 and 439:
AUTHOR INDEX GARCIA MOYANO M., PA23
Page 440 and 441:
AUTHOR INDEX GORHAM J., PA2820 GORI
Page 442 and 443:
AUTHOR INDEX HANIBUCHI M., PA778 HA
Page 444 and 445:
AUTHOR INDEX HOLMES L., PA4101, PA4
Page 446 and 447:
AUTHOR INDEX JADDOE V., PA3134 JADH
Page 448 and 449:
AUTHOR INDEX KANG B., PA1160, 2485
Page 450 and 451:
AUTHOR INDEX KJELDGAARD P., PA1125,
Page 452 and 453:
AUTHOR INDEX KUNA P., OA256, PA964,
Page 454 and 455:
AUTHOR INDEX PA5096 LEPEJ D., PA129
Page 456 and 457:
AUTHOR INDEX PA1311 MACEDO C., PA25
Page 458 and 459:
AUTHOR INDEX MARTÍNEZ-MEMIJE R., P
Page 460 and 461:
AUTHOR INDEX MIKURA S., PA4847 MILA
Page 462 and 463:
AUTHOR INDEX MOYA A., PA3762 MOYA A
Page 464 and 465:
AUTHOR INDEX NIKOLETOU D., PA1368 N
Page 466 and 467:
AUTHOR INDEX PA1569 OUPADIA S., PA2
Page 468 and 469:
AUTHOR INDEX OA1802, PA2083, PA2373
Page 470 and 471:
AUTHOR INDEX PPATHANASSIOU E., PA41
Page 472 and 473:
AUTHOR INDEX PA4311, PA4325 RIBEIRO
Page 474 and 475:
AUTHOR INDEX SABOGAL PINEROS Y., PA
Page 476 and 477:
AUTHOR INDEX SCHMIDT A., PA902 SCHM
Page 478 and 479:
AUTHOR INDEX SIMIDCHIEV A., PA300 S
Page 480 and 481:
AUTHOR INDEX STANCHEVA G., PA2854,
Page 482 and 483:
AUTHOR INDEX PA4357, PA4359 TAN L.,
Page 484 and 485:
AUTHOR INDEX TRIEBNER K., 629, OA49
Page 486 and 487:
AUTHOR INDEX PA601, PA1825, 2903, 3
Page 488 and 489:
AUTHOR INDEX PA3864, 4501, 4856 WAL
Page 490 and 491:
AUTHOR INDEX YAMAMOTO A., PA569, PA
show all

CONGRESS GUIDE

Create successful ePaper yourself

Delete template?

Save as template?